GlassScriptPhysician profile
Troy G New
NPI 1962408062
$18,332.30
in general payments reported to CMS, 2019-2025
29 companies · $9,219 in 2025
The $9,219 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $288 · 2021: $377 · 2022: $55.45 · 2023: $41.20 · 2024: $8,069 · 2025: $9,219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,200.00 |
| Food and Beverage | $129.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $17,200.00 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $205.05 | 2019-2022 | |
| Exeltis, USA INC. | $150.06 | 2019-2024 | Slynd |
| Therapeuticsmd, INC. | $94.60 | 2020-2021 | |
| Amag Pharmaceuticals, INC. | $63.22 | 2019-2020 | |
| Lupin INC. | $56.85 | 2019-2020 | |
| Astellas Pharma US INC | $39.41 | 2023-2025 | Veozah |
| Agile Therapeutics, INC. | $38.50 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $37.65 | 2020-2023 | Exparel |
| Ethicon US, LLC | $37.40 | 2022 | |
| Merck Sharp & Dohme LLC | $34.20 | 2021 | |
| Evofem Biosciences, INC. | $32.64 | 2021 | |
| Hologic Sales and Service, LLC | $28.43 | 2019 | |
| Avion Pharmaceuticals | $28.26 | 2019-2021 | |
| Aspira Women'S Health INC | $26.35 | 2020-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $23.91 | 2021 | |
| Biogen, INC. | $22.98 | 2024 | Zurzuvae |
| Duchesnay USA Incorporated | $22.73 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.10 | 2019 | |
| Mallinckrodt Hospital Products INC. | $21.98 | 2020 | |
| Organon LLC | $20.51 | 2024 | |
| Pfizer INC. | $20.18 | 2019 | |
| Millicent US INC | $19.79 | 2020 | |
| Becton, Dickinson and Company | $19.69 | 2021 | |
| Sage Therapeutics, LLC | $15.29 | 2021 | |
| Mallinckrodt Enterprises LLC | $13.81 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.66 | 2021 | |
| Channel Medsystems, INC. | $11.98 | 2024 | |
| Allergan, INC. | $11.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy New listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.